Download PDF
Thromb Haemost 1997; 78(01): 297-301
DOI: 10.1055/s-0038-1657542
Thrombophilia as a multigenic disorder
Schattauer GmbH Stuttgart

Thrombophilia as a Multigenic Disorder

Uri Seligsohn
Department of Hematology, Sheba Medical Center, Tel-Hashomer, Israel
,
Ariella Zivelin
Department of Hematology, Sheba Medical Center, Tel-Hashomer, Israel
› Author Affiliations
Further Information

Publication History

Publication Date:
12 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Lane DA, Mannucci PM, Bauer KA, Benina RM, Bochkov NP, Boulyjenkov V, Chandy M, Dahlback B, Ginter EK, Miletich JP, Rosendaal FR, Seligsohn U. Inherited thrombophilia: Part 1. Thromb Haemost 1996; 76: 651-652
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, Chandy M, Dahlback B, Ginter EK, Miletich JP, Rosendaal FR, Seligsohn U. Inherited thrombophilia: Part 2. Thromb Haemost 1996; 76: 823-834
    PubMedGoogle Scholar
  • 3 Miletich JP, Prescott SM, White R, Majerus PW, Bovill EG. Inherited predisposition to thrombosis. Cell 1993; 72: 477-480
    CrossrefPubMedGoogle Scholar
  • 4 Dahlback B. Inherited thrombophilia: Resistance to activated protein C as a pathogenic factor of venous thromboembolism. Blood 1995; 85: 607-614
    PubMedGoogle Scholar
  • 5 Falcon CR, Cattaneo M, Panzeri D, Martinelli I, Mannucci PM. High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis. Arterioscl Thromb 1994; 14: 1080-1083
    CrossrefPubMedGoogle Scholar
  • 6 Den HeijerM, Blom HJ, Gerrits WB, Rosendaal FR, Haak HL, Wijermans PW, Bos GMJ. Is hyperhomocysteinemia a risk factor for recurrent venous thrombosis?. Lancet 1995; 345: 882-885
    CrossrefPubMedGoogle Scholar
  • 7 Fermo I, D’Angelo SV, Paroni R, Mazzola G, Calori G, D’Angelo A. Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease. Ann Int Med 1995; 123: 747-753
    CrossrefPubMedGoogle Scholar
  • 8 Simioni P, Prandoni P, Burlina A, Tormene D, Sardella C, Ferrari V, Benedetti L, Girolami A. Hyperhomocysteinemia and deep-vein thrombosis. Thromb Haemost 1996; 76: 883-886
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Den HeijerM, Koster T, Blom JH, Bos GMJ, Briet E, Reitsma PH, Vandenbroucke JP, Rosendaal FR. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996; 334: 759-762
    CrossrefPubMedGoogle Scholar
  • 10 Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 1995; 274: 1049-1057
    CrossrefPubMedGoogle Scholar
  • 11 Mudd SH, Levy HL, Skovby B. Disorders of trans-sulfuration. In: The Metabolic and Molecular Bases of Inherited Disease. Scriver CT, Beaudet AL, Sly WS, Valle D. (eds). 7. th ed McGraw-Hill; New York: 1995. pp 1279-1327
    Google Scholar
  • 12 Kang SS, Wong PWK, Susmano A, Sora J, Morusis M, Ruggie N. Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet 1991; 48: 536-545
    PubMedGoogle Scholar
  • 13 Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den HeijerM, Kluigtmans LAJ, van denHeuvelLP, Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genet 1995; 10: 111-113
    CrossrefPubMedGoogle Scholar
  • 14 Kluijtmans LAJ, van den HeuvelLPWJ, Boers GHJ, Fross P, Stevens EMB, van Oost BA, den Jeijer M, Trijbels FJM, Rozen R, Blom HJ. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 1996; 58: 35-41
    PubMedGoogle Scholar
  • 15 Motulsky AG. Nutritional ecogenetics: Homocysteine-related arteriosclerotic vascular disease neural tube defects and folic acid. Am J Hum Genet 1996; 58: 17-20
    PubMedGoogle Scholar
  • 16 Allaart CF, Poort SR, Rosendaal FR, Reitsma PH, Bertina RM, Briet E. Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet 1993; 341: 134-138
    CrossrefPubMedGoogle Scholar
  • 17 Ben-Tal O, Zivelin A, Seligsohn U. The relative frequency of hereditary thrombotic disorders among 107 patients with thrombophilia in Israel. Thromb Haemost 1989; 61: 50-54
    Article in Thieme ConnectPubMedGoogle Scholar
  • 18 Koeleman BPC, Reitsma PH, Allaart CF, Bertina RM. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood 1994; 84: 1031-1035
    PubMedGoogle Scholar
  • 19 Seligsohn U, Berger A, Abend M, Rubin L, Attias D, Zivelin A, Rapaport SI. Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med 1984; 310: 559-562
    CrossrefPubMedGoogle Scholar
  • 20 Brenner B, Zivelin A, Lanir N, Greengard JS, Griffin JH, Seligsohn U. Venous thromboembolism associated with double heterozygosity for R506Q mutation of factor V and for T298M mutation of protein C in a large family of a previously described homozygous protein C-deficient newborn with massive thrombosis. Blood 1996; 88: 877-880
    PubMedGoogle Scholar
  • 21 Gandrille SG, Greengard JS, Alhenc-Geleas M, Juhan-Vague I, Abgrall JF, Jude B, Griffin JH, Aiach M. The French Network on behalf of INSERM. Incidence of activated protein C resistance caused by the ARG 506 GLN mutation in factor V in 113 unrelated symptomatic protein C-deficient patients. Blood 1995; 86: 219-224
    PubMedGoogle Scholar
  • 22 Hallam PJ, Millar DS, Krawczak M, Kakkar VV, Cooper DN. Population differences in the frequency of the factor V Leiden variant among people with clinically symptomatic protein C deficiency. J Med Genet 1995; 32: 543-545
    CrossrefPubMedGoogle Scholar
  • 23 Gandrille S, Borgel D, Aiach M. The French Network INSERM on molecular abnormalities responsible for protein C and protein S deficiencies. Incidence of activated protein C resistance due to ARG 506 GLN mutation in factor V in 116 unrelated propositus from families with protein S deficiency. Thromb Haemost 1995; 73: 1372 (abst)
    PubMedGoogle Scholar
  • 24 Zoller B, Bemtsdotter A, de Frutos PG, Dahlback B. Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood 1995; 85: 3518-3523
    PubMedGoogle Scholar
  • 25 Koeleman BPC, van Rumpt D, Hamulyak K, Reitsma PH, Bertina RM. Factor V Leiden: An additional risk factor for thrombosis in protein S deficient families?. Thromb Haemost 1995; 74: 580-583
    Article in Thieme ConnectPubMedGoogle Scholar
  • 26 Beauchamp NJ, Daly ME, Cooper PC, Makris M, Preston FE, Peake IR. Molecular basis of protein S deficiency in three families also showing independent inheritance of factor V Leiden. Blood 1996; 88: 1700-1707
    PubMedGoogle Scholar
  • 27 Van BovenHH, Reitsma PH, Rosendaal FR, Bayston TA, Chowdhuiy V, Bauer KA, Scharrer I, Conrad J, Lane DA. Factor Leiden (FV R506Q) in families with inherited antithrombin deficiency. Thromb Haemost 1996; 75: 417-421
    Article in Thieme ConnectPubMedGoogle Scholar
  • 28 Ireland H, Bayston TA, Chowdhury V, Thein SL, Conard J, Pabinger I, Lane DA. Factor V Leiden as an independent risk factor for thrombosis in antithrombin deficiency type II. Heparin binding site. Thromb Haemost 1995; 73: 1361 (Abst)
    Article in Thieme ConnectPubMedGoogle Scholar
  • 29 Mandel H, Brenner B, Berant M, Rosenberg N, Lanir N, Jakobs C, Fowler B, Seligsohn U. Coexistence of hereditary homocystinuria and factor V Leiden — Effect on thrombosis. N Engl J Med 1996; 334: 763-768
    CrossrefPubMedGoogle Scholar
  • 30 D’Angelo A, Fermo I, D’Angelo SV. Thrombophilia, homocystinuria, and mutation of the factor V gene. N Engl J Med 1996; 335: 289
    CrossrefPubMedGoogle Scholar
  • 31 Trillot N, Preudhomme C, Alhence-Gelas M, Gaveriaux V, Bauters A, Gandrille S, Aiach M, Jude B. Thermolabile methylene tetrahydrofolate reductase (MTHFR) does not modify the risk for venous thromboembolism in subjects with heterozygous factor V Leiden. Blood 1996; 88 01 284a
    PubMedGoogle Scholar
  • 32 Peng F, Triplett D, Bama L. Evaluation of patients with thrombosis for coexistence of factor V Leiden and methylenetetra- hydrofolate reductase C677T thermolabile mutation. Haemostasis 1996; 26 (Suppl. 03) 446 a
    PubMedGoogle Scholar
  • 33 Cattaneo M, Tsai MY, Bucciarelli P, Taili E, Zighetti ML, Bignell M, Mannucci PM. A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (factor ViQ506). Blood 1996; 88 (Suppl. 01) 285 a
    PubMedGoogle Scholar
  • 34 Greengard JS, Alhence-Gelas M, Gandrille S, Emmerich J, Aiach M, Griffin JH. Pseudo-homozygous protein C resistance due to coinheritance of heterozygous factor V-R506Q and type I factor deficiency associated with thrombosis. Thromb Haemost 1995; 73: 1361 (Abst)
    Article in Thieme ConnectPubMedGoogle Scholar
  • 35 Simioni P, Scudeller A, Radossi P, Gavasso S, Girolami B, Tormene D, Girolami A. “Pseudo homozygous” activated protein C resistance due to double heterozygous factor V defects (factor Leiden mutation and type I quantitative factor V defect) associated with thrombosis. Report of two cases belonging to two unrelated kindreds. Thromb Haemost 1996; 75: 422-426
    Article in Thieme ConnectPubMedGoogle Scholar
  • 36 Zehnder L, Jain M. Recurrent thrombosis due to compound heterozygosity for factor V Leiden and factor V deficiency. Blood Coagul Fibrinol 1996; 07: 361-362
    CrossrefPubMedGoogle Scholar
  • 37 Nichols WC, Amano K, Cacheris PM, Figueiredo MS, Michaelides K, Schwaab R, Hoyer L, Kaufman RJ, Ginsburg D. Moderation of hemophilia A phenotype by the factor V R506Q mutation. Blood 1996; 88: 1183-1187
    CrossrefPubMedGoogle Scholar
  • 38 Chan J, Weinmann AF, Thompson AR. Factor V Arg/Gln506has no dominant influence on the severity of hemophilia when inherited concurrently. Thromb Haemost 1995; 73: 1368 a
    Article in Thieme ConnectPubMedGoogle Scholar
  • 39 Arbini AA, Mannucci PM, Bauer KA. Low prevalence of the factor V Leiden mutation among “severe” hemophiliacs with a “Milder” bleeding diathesis. Thromb Haemost 1995; 74: 1255-1258
    Article in Thieme ConnectPubMedGoogle Scholar
  • 40 Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-1134
    CrossrefPubMedGoogle Scholar
  • 41 Zivelin A, Griffin JH, Xu X, Pabinger I, Samama M, Conard J, Brenner B, Eldor A, Seligsohn U. A single genetic origin for a common Caucasian risk factor for venous thrombosis. Blood. in press
    Google Scholar
  • 42 Dahlback B. Are we ready for factor V Leiden screening?. Lancet 1996; 347: 1346-1347
    PubMedGoogle Scholar
  • 43 Tosetto A, Gatto E, Rodeghiero F. APC resistance (FV Leiden) has a higher prevalence in females. Preliminary results from the Vicenza thrombophilia and arteriosclerosis (VITA) project. Thromb Haemost 1995; 73: 1124 a
    PubMedGoogle Scholar
  • 44 Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996; 93: 07-09
    CrossrefPubMedGoogle Scholar
  • 45 Jobin F, Vu L, Lessard M. Two cases of inherited triple deficiency in a large kindred with thrombotic diathesis and deficiencies of antithrombin m, heparin cofactor II, protein C and protein S. Thromb Haemost 1991; 66: 295-299
    Article in Thieme ConnectPubMedGoogle Scholar
  • 46 Zoller B, He X, Dahlback B. Homozygous APC-resistance combined with inherited type I protein S deficiency in a young boy with severe thrombotic disease. Thromb Haemost 1995; 73: 743-745
    Article in Thieme ConnectPubMedGoogle Scholar
  • 47 Koller H, Stoll G, Sitzer M, Burk M, Schottler B, Freund JH. Deficiency of both protein C and protein S in a family with ischemic strokes in young adults. Neurol 1994; 44: 1238-1240
    CrossrefPubMedGoogle Scholar
  • 48 Franken DG, Vreugdenhil A, Boers GHJ, Verrips A, Blom HJ, Novakova IRO. Familiar cerebrovascular accidents due to concomitant hyperhomocysteinemia and protein C deficiency type 1. Stroke 1993; 24: 1599-1600
    CrossrefPubMedGoogle Scholar
  • 49 Ironi A, Lubetzky A, Seligsohn U. Massive thrombosis in a patient doubly homozygous for FV-R506Q and MTHFR- thermolability. Unpublished
    PubMedGoogle Scholar
  • 50 Gallagher PM, Meleady R, Shields DC, Kok SoonT, McMaster RozenR, Evans A, Graham IM, Whitehead AS. Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation. Circulation 1996; 94: 2154-2158
    CrossrefPubMedGoogle Scholar
  • 51 Wilcken DEL, Wang XL, Sim AS, McCredie RM. Distribution in healthy and coronary populations of the methylenetetrahydrofolate reductase (MTHFR) C677T mutation. Arterioscler Thromb Vase Biol 1996; 16: 878-882
    CrossrefPubMedGoogle Scholar
  • 52 Schmitz C, Lindpainter K, Verhoef P, Graziano JM, Buring J. Genetic polymorphism of methylenetetrahydrofolate reductase and myocardial infarction. A case-control study. Circulation 1996; 94: 1812-1814
    CrossrefPubMedGoogle Scholar
  • 53 Deloughery TG, Evans A, Sadeghi A, McWilliams J, Henner WD, Taylor Jr LM, Press RD. Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease. Circulation 1996; 94: 3074-3078
    CrossrefPubMedGoogle Scholar
  • 54 Adams M, Smith PD, Martin D, Thompson JR, Lodwick D, Samani NJ. Genetic analysis of thermolabile methylenetetrahydrofolate reductase as a risk factor for myocardial infarction. Q J Med 1996; 89: 437-444
    CrossrefPubMedGoogle Scholar
  • 55 Ma J, Stampfer MJ, Hennekens CH, Frosst P, Selhub J, Horsford J, Malinow MR, Willet WC, Rozen R. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation 1996; 94: 2410-2416
    CrossrefPubMedGoogle Scholar